Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Revive Therapeutics Ltd C.RVV

Alternate Symbol(s):  RVVTF

Revive Therapeutics Ltd. is a Canada-based life sciences company. The Company is focused on the research and development of therapeutics and diagnostics for infectious diseases, medical countermeasures, and rare disorders. It is engaged in exploring the use of Bucillamine for the potential treatment of nerve agent exposure and long COVID. The Company, through its diagnostics division, is evaluating a point-of-care in vitro diagnostic device that aids in the detection of post COVID-19 conditions or Long COVID. It also advancing the development of Psilocybin-based therapeutics through various programs. The Company's subsidiaries include Revive Therapeutics Inc. (Ontario), Revive Diagnostics Inc., and Psilocin Pharma Corp. (Ontario).


CSE:RVV - Post by User

Bullboard Posts
Post by 2skytracker2on Feb 15, 2020 4:54pm
65 Views
Post# 30695997

Skeptical!

Skeptical!Firstly, I am long Rvv but must ask, does this new company produce products, and are those products currently on shelves? In other words, do they have a revenue stream? if not we are going to dilute our share value by more than 75%. We will go from 72mil to 127mil shares outstanding.On the other hand if they do have a pipeline and can provide inroads for other products it could be a good move. Without more information ( metrics ) i'm not on this band wagon. I have been accumulating and holding shares for 3 years and don't mind waiting for Revive to put their own products on the shelf, thereby creating cashflow at which point M&A would be good and would not dilute our share value. GLTA!!

Bullboard Posts